| Financial Year |
March 31 2023 |
| Monetary Funds |
489,531,384.60 |
| Held-for-trading Financial Assets |
10,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
882,139,325.53 |
| Advances to Suppliers |
22,985,866.98 |
| Other Receivables |
20,230,586.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
43,131,284.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
105,641,541.27 |
| Other Current Assets |
177,424,851.34 |
| Total Current Assets |
1,741,094,841.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,383,790,784.47 |
| Long-term Equity Investment |
55,275,732.47 |
| Investment Properties |
-- |
| Fixed Assetes |
57,830,170.54 |
| Under-construction Projects |
400,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,776,182,956.45 |
| R&D expenses |
-- |
| Goodwill |
26,370,263.49 |
| Long-Term Deferred and Prepaid Expenses |
860,152.34 |
| Deferred Income Tax Assets |
31,335,104.23 |
| Other Non-Current Assets |
215,343,205.64 |
| Sub-Total of Non-Current Assets |
8,547,788,300.49 |
| Total Assets |
10,288,883,141.98 |
| Short-Term Loans |
527,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
830,209,775.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
649,077.59 |
| Taxes Payable |
23,710,402.87 |
| Interest Payable |
9,479,081.24 |
| Dividend Payable |
-- |
| Other payables |
22,075,517.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
412,811,170.39 |
| Other Current Liabilities |
12,085,148.95 |
| Sub-Total of Current Liabilities |
1,850,250,336.51 |
| Long-term Loans |
5,064,052,416.92 |
| Bonds Payable |
164,614,977.51 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
79,988,050.66 |
| Deferred Income Tax Liabilities |
101,095,742.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,409,751,187.14 |
| Total Liabilities |
7,260,001,523.65 |
| Paid-In Capital(Or Share Stock) |
584,118,165.00 |
| Capital Surplus |
1,122,261,600.41 |
| Surplus Reserve |
50,869,255.55 |
| LESS:Treasury Stock |
50,120,526.99 |
| Undistributed Profits |
1,109,003,532.72 |
| Minority Stockholder's Interest |
176,462,243.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,852,419,375.29 |
| Owner's Equity（Stockholder's Equity） |
3,028,881,618.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,288,883,141.98 |
